Short Term Effects of Waon Therapy on Patients with Chronic Heart Failure: Prospective Multicenter Clinical Trial by Waon Equipment
Not Applicable
- Conditions
- Chronic Heart Failure
- Registration Number
- JPRN-UMIN000006705
- Lead Sponsor
- Cardiovascular Medicine and Hypertension
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 152
Inclusion Criteria
Not provided
Exclusion Criteria
1) 1) Untreated HF patients 2) Severe aortic stenosis which pressure gradient is 50 mmHg or more. 3) Hypertrophic obstructive cardiomyopathy with severe LV and out-flow obstruction (the pressure gradient is 50 mmHg or more). 4) Patients with active infection or fever with 37 cent-degrees or more. 5) Patients who had myocardial infarction or stroke within 6 months. 6) Cancer, or less than 5 years from healing cancer. 7) Patients treated with hemodialysis 8) Patients whose body weight is 135 kg or more. 9) Patients who are judged as inappropriate subjects by physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of plasma BNP levels 2 weeks after the start of study.
- Secondary Outcome Measures
Name Time Method YHA functional class, 6 min walk distance, cardiothoracic ratio of chest Xp, ejection fraction of echocardiogram, heart rate, arrhythmia, bundle branch block, incidence of adverse event